Winning Health(SZ:300253) Chang Jiang Shang Bao·2025-11-06 08:41Core Viewpoint - The recent legal issues surrounding the actual controller of Weining Health, Zhou Wei, have led to significant impacts on the company's stock price and financial performance, with a notable decline in revenue and profits [1][3][4]. Group 1: Legal Issues - Weining Health's actual controller, Zhou Wei, has been involved in a bribery scandal, receiving a criminal sentence for unit bribery, with a fine of 800,000 yuan for the company and a prison sentence of 18 months for Zhou Wei [1][2]. - Zhou Wei has a history of alleged bribery dating back to 2011, where he reportedly bribed a member of the IPO review committee to facilitate the company's IPO [2]. Group 2: Financial Performance - Weining Health's revenue and net profit for 2024 were reported at 2.782 billion yuan and 87.8932 million yuan, respectively, reflecting a year-on-year decline of 12.05% and 75.45% [3]. - In the first three quarters of 2025, the company reported revenue of 1.295 billion yuan, a year-on-year decrease of 32.27%, and a net loss of 241 million yuan, marking a significant decline compared to previous years [3][5]. Group 3: Business Operations - The company focuses on medical software development, sales, and technical services, aiming to enhance its core business through AI-driven products and technology [4]. - Challenges such as deferred customer demand, ongoing product upgrades, and operational costs have contributed to the decline in revenue and the emergence of losses [4].